Literature DB >> 25266854

Risk of infection and associated influenza-like disease among abattoir workers due to two Leptospira species.

A Dreyfus1, C Heuer1, P Wilson2, J Collins-Emerson2, M G Baker3, J Benschop2.   

Abstract

The aims of this study were to determine the annual incidence of infection with Leptospira interrogans serovar Pomona and/or Leptospira borgpetersenii serovar Hardjo and its association with influenza-like illness (ILI) in meat workers in New Zealand. Sera were collected twice, 50-61 weeks apart, from 592 workers at eight abattoirs slaughtering sheep (n = 4), cattle (n = 2) and deer (n = 2), and tested by the microscopic agglutination test for Hardjo and Pomona. Forty-nine (8·3%) participants either seroconverted or had at least a twofold increased serological titre against either serovar. The worker infection risk was higher in sheep abattoirs (11·9%) than in abattoirs processing deer (0%) or cattle (1·2%) (P < 0·01). The annualized risk of mild (ILI) or severe clinical disease attributable to the two Leptospira serovars was 2·7%. This study has demonstrated that meat workers are at substantial risk of infection and clinical disease, suggesting further investigation of infection sources and preventive measures are warranted.

Entities:  

Keywords:  Abattoir worker; Hardjo; Pomona; clinical illness; incidence; infection; leptospirosis; population attributable risk; risk

Mesh:

Substances:

Year:  2014        PMID: 25266854      PMCID: PMC9506980          DOI: 10.1017/S0950268814002477

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  17 in total

1.  Assessment of occupational exposure to leptospirosis in a sheep-only abattoir.

Authors:  S Dorjee; C Heuer; R Jackson; D M West; J M Collins-Emerson; A C Midwinter; A L Ridler
Journal:  Epidemiol Infect       Date:  2010-09-15       Impact factor: 2.451

2.  Fifty years of leptospirosis research in New Zealand: a perspective.

Authors:  R B Marshall; B W Manktelow
Journal:  N Z Vet J       Date:  2002       Impact factor: 1.628

Review 3.  Leptospirosis presenting to an intensive care unit in provincial New Zealand: a case series and review.

Authors:  Bevan Vickery; Sharyn A Flynn; Lester Calder; Ross C Freebairn
Journal:  Crit Care Resusc       Date:  2006-09       Impact factor: 2.159

Review 4.  Leptospirosis in New Zealand: an ecological view.

Authors:  S C Hathaway
Journal:  N Z Vet J       Date:  1981-07       Impact factor: 1.628

5.  Changing epidemiology of human leptospirosis in New Zealand.

Authors:  C N Thornley; M G Baker; P Weinstein; E W Maas
Journal:  Epidemiol Infect       Date:  2002-02       Impact factor: 2.451

6.  Leptospirosis in meat inspectors: preliminary results of a serological survey.

Authors:  D K Blackmore; L Bell; L Schollum
Journal:  N Z Med J       Date:  1979-11-28

7.  Serological follow-up of patients involved in a localized outbreak of leptospirosis.

Authors:  R Lupidi; M Cinco; D Balanzin; E Delprete; P E Varaldo
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

8.  Persistence of anti-leptospiral IgM, IgG and agglutinating antibodies in patients presenting with acute febrile illness in Barbados 1979-1989.

Authors:  P Cumberland; C O Everard; J G Wheeler; P N Levett
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

9.  Seroepidemiology and serological follow-up of anti-leptospiral IgG in children in Southern Vietnam.

Authors:  Khoa T D Thai; Tran Thi Thanh Nga; Hoang Lan Phuong; Phan Trong Giao; Le Quoc Hung; Tran Quang Binh; Nguyen Van Nam; Rudy A Hartskeerl; Peter J de Vries
Journal:  Acta Trop       Date:  2008-02-29       Impact factor: 3.112

10.  Sero-prevalence and risk factors for leptospirosis in abattoir workers in New Zealand.

Authors:  Anou Dreyfus; Jackie Benschop; Julie Collins-Emerson; Peter Wilson; Michael G Baker; Cord Heuer
Journal:  Int J Environ Res Public Health       Date:  2014-02-05       Impact factor: 3.390

View more
  7 in total

1.  Effects of Accounting for Interval-Censored Antibody Titer Decay on Seroincidence in a Longitudinal Cohort Study of Leptospirosis.

Authors:  Katharine A Owers Bonner; Jaqueline S Cruz; Gielson A Sacramento; Daiana de Oliveira; Nivison Nery; Mayara Carvalho; Federico Costa; James E Childs; Albert I Ko; Peter J Diggle
Journal:  Am J Epidemiol       Date:  2021-05-04       Impact factor: 4.897

2.  Prevalence and risk factors for Leptospira exposure in New Zealand veterinarians.

Authors:  J M Sanhueza; C Heuer; P R Wilson; J Benschop; J M Collins-Emerson
Journal:  Epidemiol Infect       Date:  2015-03-25       Impact factor: 4.434

3.  Inhibitory effect of BMAP-28 on Leptospiral Lipopolysaccharide-Induced TLR2-Dependent Immune Response in Bovine Cells.

Authors:  Yijie Guo; Cuiping Ding; Bo Zhang; Jun Xu; Meng Xun; Jiru Xu
Journal:  Jundishapur J Microbiol       Date:  2016-06-21       Impact factor: 0.747

4.  Data on Leptospira interrogans sv Pomona infection in Meat Workers in New Zealand.

Authors:  M Pittavino; A Dreyfus; C Heuer; J Benschop; P Wilson; J Collins-Emerson; P R Torgerson; R Furrer
Journal:  Data Brief       Date:  2017-06-08

5.  Diverse Epidemiology of Leptospira serovars Notified in New Zealand, 1999-2017.

Authors:  Shahista Nisa; David A Wilkinson; Olivia Angelin-Bonnet; Shevaun Paine; Karen Cullen; Jackie Wight; Michael G Baker; Jackie Benschop
Journal:  Pathogens       Date:  2020-10-14

6.  Neglected zoonotic agents in cattle abortion: tackling the difficult to grow bacteria.

Authors:  Sara Vidal; Kristel Kegler; Gilbert Greub; Sebastien Aeby; Nicole Borel; Mark P Dagleish; Horst Posthaus; Vincent Perreten; Sabrina Rodriguez-Campos
Journal:  BMC Vet Res       Date:  2017-12-02       Impact factor: 2.741

7.  Cross-Sectional Serological Survey for Leptospira spp. in Beef and Dairy Cattle in Two Districts in Uganda.

Authors:  Anou Dreyfus; Terence Odoch; Lordrick Alinaitwe; Sabrina Rodriguez-Campos; Amanuel Tsegay; Valentine Jaquier; Clovice Kankya
Journal:  Int J Environ Res Public Health       Date:  2017-11-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.